Newsroom
Newsroom
Media Coverage
February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Press Release
February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Press Release
February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Perspectives
February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics.
We believe private equity is well-positioned to drive and scale ESG best practices.
The...
Press Release
February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Press Release
January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Press Release
December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Press Release
December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Press Release
December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
Events
December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
- ‹ previous
- 8 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Press Release
March 6, 2015
Clayton, Dubilier & Rice (“CD&R”) today announced that Ravi Sachdev, former Managing Director for Healthcare Coverage and Co-Head of Healthcare Services at J.P. Morgan, will join the Firm as a Partner.
Mr. Sachdev brings to CD&R...
Media Coverage
November 2, 2014
As part of its annual Awards for Operational Excellence, Private Equity International recognized CD&R’s Rexel investment in October 2014. Under CD&R’s ownership, Rexel built market leadership positions in developed and emerging markets...
Press Release
August 24, 2014
Clayton, Dubilier & Rice (“CD&R”) and MAUSER Group (“MAUSER”) announced today that funds managed by CD&R have completed the previously-announced acquisition of MAUSER, one of the world;s leading industrial packaging companies. The...
Press Release
August 21, 2014
CHC Group Ltd. (NYSE: HELI) and Clayton, Dubilier & Rice (CD&R) today announced they have entered into definitive agreements for CD&R managed funds to invest $500 million in CHC through the purchase of convertible preferred shares to be...
Press Release
August 1, 2014
Ashland Water Technologies has a new name - Solenis. Rooted in “solutions” and “genesis,” the name underscores the company’s mission to be at the source - the genesis - of solutions for its customers.
The name change coincides with the acquisition...
Press Release
July 1, 2014
Clayton, Dubilier & Rice (“CD&R”) and Healogics Holding Corp. (“Healogics”) announced today that funds managed by CD&R have completed the previously-announced acquisition of Healogics, the largest advanced wound care services provider in...
Press Release
May 9, 2014
As an extraordinarily effective and inspirational executive, B. Charles “Chuck” Ames has used his leadership position and vast knowledge to help educate and assist the next generation of management leaders as a mentor, collaborator, author and...
Press Release
February 18, 2014
Clayton, Dubilier & Rice (“CD&R”) and Ashland Inc. (NYSE:ASH) today announced an agreement under which a CD&R-managed fund will acquire Ashland Water Technologies (“AWT”), a leading global supplier of specialty chemicals for process,...
Press Release
January 29, 2014
Clayton, Dubilier & Rice (“CD&R”) today announced the close of an investment in PharMEDium Healthcare Corporation (“PharMEDium” or the “Company”), the leading national provider of hospital pharmacy-outsourced sterile compounding services....
Press Release
December 19, 2013
PharMEDium, the leading national provider of hospital pharmacy-outsourced sterile compounding services, today announced an agreement under which a fund managed by Clayton, Dubilier & Rice (CD&R) will invest in the company. Oak Investment...
- ‹ previous
- 25 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.